Biomarker Surrogate Endpoints Get Mixed Reviews At NCI Workshop
This article was originally published in The Tan Sheet
Executive Summary
Researchers should be cautious when using biomarkers as surrogate endpoints in cancer studies, Chief of the National Cancer Institute's Nutritional Epidemiology branch Arthur Schatzkin, MD stated July 12